Maryellen Lively

Maryellen Lively, MBA has a diverse work experience in various roles and industries. Maryellen began their career as a Business Team Leader at Rhone-Poulenc Rorer from 1989 to 1996. Maryellen then worked as a Cardiovascular Specialist at Novartis from 1997 to 1999, followed by a role as a Diabetes Specialist at Takeda Pharmaceuticals in 1999.

In 2005, Maryellen joined OnCall-LLC where they held multiple positions. Maryellen started as a Manager of Business Development and was responsible for selling OnCall's suite of contract sales and marketing services. Maryellen identified opportunities for new business and secured new clients through contacts with senior-level executives.

In 2011, Maryellen was promoted to Client Services Director, where they developed marketing programs and materials for new and emerging companies. Maryellen oversaw market development, established vendor relationships, and secured additional resources for marketing, PR, distribution, and procurement needs. Maryellen also worked cross-functionally with internal partners on new product launches.

Since 2014, Maryellen has been working as the Director of Public Health Programs at OnCall-LLC. In this role, they oversee project operations for the NYC Department of Health and Mental Hygiene and other health departments within the U.S. Maryellen is responsible for managing public health education campaigns.

Overall, Maryellen Lively has demonstrated their expertise in sales, marketing, project management, and public health programs throughout their career.

Maryellen Lively holds an MBA from Saint Joseph's University - Erivan K. Haub School of Business, with a focus on Pharmaceutical & Healthcare Marketing. Maryellen also completed a Mini-MBA in Digital Marketing from Rutgers Business School. Prior to their postgraduate studies, Maryellen obtained a Bachelor of Arts degree from Siena College, majoring in English and Business. In addition to their formal education, they have obtained a certification titled "The Secret to Better Decisions: Stop Hoarding Chips" from LinkedIn in October 2021.